Orsay, France

Gérard Moinet

This inventor holds 5 USPTO granted patents. Top assignees: Merck Patent Gmbh, Merck Patent Gesellschaft, Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 2001-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gérard Moinet. Retrieved from https://idiyas.com/inventor/gandeacuterard-moinet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Gérard Moinet: Innovator in Pharmaceutical Chemistry

Introduction

Gérard Moinet is a notable inventor based in Orsay, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues. With a total of 5 patents to his name, Moinet's work has had a meaningful impact on therapeutic applications.

Latest Patents

Among his latest patents is a pharmaceutical composition comprising a compound of general formula (I), which includes (Aminoiminomethyl) amino) alkane-carboxamides. This invention is particularly relevant for treating pathologies associated with insulin resistance syndrome. Another significant patent involves Thiazolidone-2 derivatives, which are 4-diketone substituted, along with methods for obtaining them and pharmaceutical compositions containing these derivatives.

Career Highlights

Moinet has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. His experience in these organizations has allowed him to refine his expertise and contribute to innovative solutions in drug development.

Collaborations

Throughout his career, Moinet has collaborated with esteemed colleagues such as Liliane Doare and Micheline R. Kergoat. These partnerships have fostered a collaborative environment that has enhanced the quality and scope of his research.

Conclusion

Gérard Moinet's contributions to pharmaceutical chemistry exemplify the importance of innovation in addressing health challenges. His patents and collaborations reflect a commitment to advancing therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…